Clinical trial
Growth Hormone Use in Adults With Prader-Willi Syndrome
NCT00444964 · Children's Mercy Hospital Kansas City, Other · Completed
Key facts
| NCT number | NCT00444964 |
|---|---|
| Title | Growth Hormone Use in Adults With Prader-Willi Syndrome |
| Official title | Growth Hormone Use in Adults With Prader-Willi Syndrome |
| Lead sponsor | Children's Mercy Hospital Kansas City, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prader-Willi Syndrome |
| Intervention type | Drug |
| Interventions | Nutropin AQ |
| Enrollment | 11 |
| Start date | Apr 1, 2005 |
| Primary completion | Jan 1, 2012 |
| Completion | Jan 1, 2012 |
| First posted | Mar 8, 2007 |
| Last update posted | Jan 8, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: